Natco Pharma - News
NSE: NATCOPHARM | BSE: 524816
₹830.00
As on 23-Sep-2026 11:24IST
Market cap
₹14,920 Cr
Revenue (TTM)
₹3,485 Cr
P/E Ratio
13
P/B Ratio
1.6
Div. Yield
0.6 %
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsNotice Of 43Rd Annual General Meeting
04-Sep-2026Board Meeting Intimation for Fund Raising
04-Sep-2026No News & Announcements are available.